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Abstract
Background: Rhinoviruses (RV) are key triggers in acute asthma exacerbations. Previous studies suggest that men
suffer from infectious diseases more frequently and with greater severity than women. Additionally, the immune
response to most infections and vaccinations decreases with age. Most immune function studies do not account
for such differences, therefore the aim of this study was to determine if the immune response to rhinovirus varies
with sex or age.
Methods: Blood mononuclear cells were isolated from 63 healthy individuals and grouped by sex and age (≤50
years old and ≥52 years old). Cells were cultured with rhinovirus 16 at a multiplicity of infection of 1. The
chemokine IP-10 was measured at 24 h as an index of innate immunity while IFNg and IL-13 were measured at
5 days as an index of adaptive immunity.
Results: Rhinovirus induced IFNg and IL-13 was significantly higher in ≤50 year old women than in age matched
men (p < 0.02 and p < 0.05) and ≥52 year old women (p < 0.02 and p > 0.005). There was no sex or age based
difference in rhinovirus induced IP-10 expression. Both IFNg and IL-13 were negatively correlated with age in
women but not in men.
Conclusions: This study suggests that pre-menopausal women have a stronger adaptive immune response to
rhinovirus infection than men and older people, though the mechanisms responsible for these differences remain
to be determined. Our findings highlight the importance of gender and age balance in clinical studies and in the
development of new treatments and vaccines.
Background
Rhinovirus (RV) infections are a key trigger for acute
exacerbations of asthma in children and adults [1-4].
There is increasing evidence that this is linked to a
subtle impairment of anti-viral immunity to RV and
possibly other viruses. The nature of this impairment is
ambiguous with some studies reporting airway epithelial
cells and alveolar macrophages from asthmatics secrete
less type I and type III interferon (IFN) than healthy
people [5,6], while other investigators dispute this find-
ing [7,8]. Altered innate immunity in asthma is not
restricted to resident cells within the lung, but also
seems to involve circulating leukocytes. Peripheral blood
mononuclear cells (PBMC) from asthmatic children and
adults show reduced IFNa secretion following in vitro
exposure to viruses [9,10], and we have recently
demonstrated reduced TLR7 function in PBMC from
adolescents with asthma [11].
Adaptive immunity is also important for host defence
against RV infection. High titres of RV specific antibo-
dies are associated with protection from infection [12]
as is the capacity of T-cells to secrete IFNg after RV sti-
mulation in vitro [13,14]. In asthma, the PBMC response
to RV is characterized by deficient Th1 immunity
[13-16], with reduced IFNg secretion being associated
with greater viral shedding after experimental RV infec-
tion [13,14].
Given that RV infections are so common, there is sur-
prisingly little known about immunity to RV in healthy
individuals; in order to fully elucidate whether there are
perturbations in response in asthmatics, further under-
standing of this issue is vital. It is clear that a variety of
infections affect men more often and more severely than
women and that women generally make stronger
immune responses to infections and vaccines compared
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to men, as reviewed by Klein et al and Fish et al [17,18].
This could also be seen utilising an ex vivo system
examining TH2 polarised cultures, where women dis-
played a stronger regulation of type 2 T cells than men
[19]. The explanation for these sex based differences
may involve hormonal and genetic factors: oestrogens,
progesterone and testosterone can all modulate many
aspects of immune function [17,18], while two key genes
involved in detecting viral RNA (TLR7 and TLR8) are
located on the X chromosome [20]. Previous studies
have also indicated that immune responses to viruses
decrease with age [21].
There is little information in the literature on whether
immune responses to RV vary in relation to sex and
age. This is an important and relevant issue for research
into respiratory diseases such as asthma where there is a
female predominance in adult life. The aim of the cur-
rent study was therefore to investigate markers of both
innate and adaptive immune responses to RV in periph-
eral blood mononuclear cells (PBMC) from healthy men
and women. The study was performed in pre- and post-
menopausal females as well as age-matched males.
Methods
Patients
We recruited healthy adult volunteers with no history of
asthma or other lung diseases. Females (n = 32) and
males (n = 31) were divided into those aged up to
50 years, and those aged 52 years and older, as the med-
ian age of menopause in Australia is 51 yrs [22]. The
women ≥52 years were not undertaking any hormonal
therapy. One woman in the ≤50 year old group was cur-
rently taking the oral contraceptive pill. The subjects of
the study had skin prick testing (SPT) to a panel of
common allergens and were questioned about symp-
toms of allergy and lung diseases. The study was
approved by the Princess Alexandra Hospital and the
University of Queensland Human Research Ethics Com-
mittees, and informed consent was obtained from each
subject.
Rhinovirus generation and titration
Ohio HeLa cells and the major group RV strain RV16
were kindly donated by Professor Phil Bardin, Monash
Medical Research Centre, Melbourne, Australia. RV
stocks were generated by passage in Ohio HeLa cells as
described previously [23] followed by purification over a
sucrose gradient [24]. To determine the optimal concen-
tration of RV, Ohio HeLa cells were seeded into a
96 well plate at a density of 1 × 104 cells per well in
150 μl RPMI containing 2% low endotoxin fetal bovine
serum (FBS; Bovogen Biologicals, Victoria) and allowed
to adhere overnight. The following day 10-fold serial
dilutions of virus was added in triplicate to the cells at
50 ul/well and cultured at 37°C for 6 days. The media
was removed and cells stained with 0.1% crystal violet
solution in PBS to determine the amount of virus
required to infect 50% of cells (TCID50).
Cell separation and culture
PBMC were isolated from heparinised blood by density
gradient centrifugation as previously described [11], and
cultured at 1 × 106 PBMC in 24 well culture plates at a
final concentration of 2 × 106 cells per/ml together with
RV16 at a multiplicity of infection (MOI) of one; i.e.
one virion per cell. Control cultures contained medium
alone. RPMI media was supplemented with antibiotics,
2-mercaptoethanol and either 10% foetal calf serum
(FCS; innate immune studies) or 5% autologous plasma
(adaptive immune studies). Extensive comparative
experiments showed that both FCS and autologous
plasma supplemented media induced identical innate
immune responses, though autologous plasma was pre-
ferred for adaptive immune studies in order to minimise
foreign antigen exposure and because autologous plasma
supplemented media was associated with consistently
higher adaptive IFNg synthesis (data not shown). The
experiments that required depletion of antigen experi-
enced/memory T cells from PBMC were performed
using CD45R0+ immuno-magnetic beads (Miltenyi Bio-
tech), according to the manufacturer’s directions. Cul-
tures were incubated at 37°C with 5% CO2 and
supernatant was harvested for cytokine quantification by
ELISA. Cell pellets were stored in ‘RNA-protect’
(Qiagen) until RNA was extracted. Initial time course
experiments indicated that optimal expression of mRNA
for IFN-stimulated genes and Th1-polarising genes was
at 6 hours post-stimulation. The optimal time point for
IFN-gamma-inducible protein 10 (IP-10, also known as
CXCL10) secretion was at 24 hours post-stimulation
while the optimal time point for the adaptive cytokines
IFNg and IL-13 was at 5 days post-stimulation.
ELISA
IP-10, IFNg and IL-13 ELISAs were performed using
commercially available paired antibodies and recombi-
nant cytokines (Becton Dickenson, Franklin Lakes, NJ).
The limit of detection was 15.6 pg/ml for IP-10 and
IFNg, and 7.8 pg/ml for IL-13. IFNa was assayed via
ELISA kit (PBL Interferon Source, Piscataway, NJ)
according to the manufacturer’s instructions; the limit
of detection for IFNa was 9.7 pg/ml.
Quantitative Real Time PCR
RNA was extracted using RNeasy Spin kit and RNA was
reverse transcribed using Quantitect reverse transcrip-
tion kit (Qiagen, Hilden, Germany), according to manu-
facturer’s instructions. Gene expression was investigated
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by quantitative PCR (qPCR), using the ABI 7900 HT
(Applied Biosystems, Foster City, CA USA) with Quanti-
tect SYBR green (Qiagen). As the expression levels in
unstimulated cultures were negligible and gene expres-
sion was induced by RV16, quantitation was achieved
using standard curve analysis [25]. Ten-fold serial dilu-
tions of PCR product standard were used to create stan-
dard curves for the gene of interest and the reference
gene UBE2D2. UBE2D2 was initially identified as a
stable reference gene in CD4+ cells [26] and subse-
quently assessed in-house to be stably expressed in total
PBMC in the absence and presence of rhinovirus 16,
using the method described by Silver et al [27]. The
resultant ratio of gene of interest to reference gene were
natural log transformed to normalise the data, allowing
parametric statistical analysis to be performed. Table 1
shows the primers used to amplify cDNA. Copy num-
bers were determined by 10-fold serial dilution of PCR
product standard and normalized to the reference gene
UBE2D2 [26]. Data are expressed as a ratio of stimu-
lated to control (unstimulated) samples.
Statistics
Statistical analysis was performed using SPSS 18 (IBM
SPSS Inc., Chicago, IL, USA). After the data was log
transformed, it was found to be normally distributed.
Group comparisons were therefore made using paired
two-tailed t-test, with p < 0.05 considered significant.
Correlations between variables were made using Pear-
son’s correlation. Raw data is presented as medians and
interquartile range, while transformed data is presented
as mean ± standard error of the mean (SEM).
Results
Sixty three healthy volunteers were recruited for the
study. The younger females were aged between 18.8 -
49.9 years, younger males were 19.0 - 47.6 years old,
older females were 53.7 - 80.7 years old while older
males were 51.9 - 81.5 years of age. Forty percent of
subjects showed minor asymptomatic atopy (SPT mean
wheal diameter ≥ 3 mm); none had symptomatic asthma
or allergic rhinitis. The proportion of subjects with a
positive SPT was similar in men and women.
The selected parameters of RV-induced innate
immune function did not vary in relation to sex or age.
Six hours after RV16 exposure, PBMC from men and
women in the younger age group showed similar expres-
sion of the IFN stimulated genes myxovirus protein A
(MxA, also known as Mx1) and 2’,5’-oligoadenylate
synthetase (OAS) (Figure 1a) and the Th1- and Th-17
polarising genes interleukin IL-12p35 and IL-23p19, as
measured by qPCR (Figure 1b). Twenty four hours after
PBMC were exposed to RV16, concentrations of IFNa
(Figure 1c) and the chemokine IP-10 (Figure 1c;
Table 2) in culture supernatants were similar in cells
derived from men and women in the younger age
bracket. Similarly, in PBMC from the older subjects
the concentration of IP-10 in supernatant 24 hours
after RV16 exposure was similar in men and women
(Table 2; Additional File 1). As IP-10 is a type I IFN
stimulated protein, and IP-10 synthesis was similar in
older men and women, other molecules in the type I
IFN pathway such as MxA, OAS and IFN-a were not
assessed in the older cohort. Further details of cytokine
production from both unstimulated and RV16 treated
cultures can be found in Table 2.
We next examined the adaptive immune response in
RV16 stimulated PBMC cultured for 5 days. RV16 expo-
sure led to the synthesis of high concentrations of IFN-g
and much smaller concentrations of IL-13 (Table 2; med-
ian IFNg = 1890 pg/ml and median IL-13 = 47.4 pg/ml,
n = 63). In order to confirm that these responses were
confined to pre-existing memory T-cells we investigated
the effect of depletion of CD45R0+ cells in a subset of
individuals (3 male and 2 female) using immuno-magnetic
beads. The depletion of CD45R0+ cells led to a >98%
reduction in IFNg and IL-13 synthesis at day 5 after RV16
stimulation, whereas sham bead depletion had no effect
(data not shown). It is therefore likely that these cytokine
responses reflect a recall or memory immune response.
RV16-induced IFNg production in the 5 day superna-
tant was significantly higher in PBMC from younger
women than in cultures from age matched men (p < 0.02)
or older women (≥52 years old; p < 0.02) (Figures 2a and
Table 2). RV16 induced IL-13 production in the 5 day
supernatant was also higher in PBMC from younger
women than in age-matched men (Figure 2b and Table 2;
p < 0.005) or older women (≥52 years old; p < 0.05). As
assessed by Pearson’s correlations, IFNg and IL-13 con-
centrations in these day 5 cultures were inversely
Table 1 Primer sequences used for quantitative real time PCR amplification
Gene Name Forward (5’ - 3’) Reverse (3’ - 5’)
Ubiquitin containing enzyme E2D2 (UBE2D2) ATGGCAGCATTTGTCTTGATATTCTAC GGATTGGGATCACACAACAGA
Myxovirus protein A (MxA) CTCGGCAACAGACTCTTCCAT CATGAAGAACTGGATGATCAAAGG
2’,5’-oligoadenylate synthetase (OAS) AGAAATACCCCAGCCAAATCTCT TGAGGAGCCACCCTTTACCA
Interleukin - 12 (IL-12)/p35 CCTTCACCACTCCCAAAACCT CCTCCACTGTGCTGGTTTTATCT
Interleukin-23 (IL-23)/p19 TGGGACACATGGATCTAAGAGAAG GAT CCT TTGCAAGCAGAACTGA
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Figure 1 Innate immune responses to rhinovirus. PBMC from younger men and women (≤50 year old) were exposed to RV16 for 6 or
24 hours. RNA was extracted from cells at 6 hours post-infection, and reverse transcribed. Real-time PCR was performed and mRNA expression
normalised to the control gene UBE2D2. (A) mRNA expression of MxA and OAS. (B) mRNA expression of IL-12/p35 and IL-23/p19. (C) Culture
supernatants were collected at 24 hours post-infection and assayed for IFNa and IP-10 by ELISA. Data were natural log transformed and are
presented as mean ± SEM.
Carroll et al. Respiratory Research 2010, 11:184
http://respiratory-research.com/content/11/1/184
Page 4 of 7
proportional to age in women, but not in men (Table 3).
No association was observed between the presence or
absence of atopy (positive SPT ≥ 3 mm) and IFNg or IL-
13 concentrations at day 5 (data not shown).
Discussion
The key finding to emerge from this study is that particu-
lar aspects of cellular immunity to RV16 vary signifi-
cantly with sex and age. In particular, PBMC from
healthy pre-menopausal women make stronger adaptive
immune responses to RV16 than men of the same age,
with higher secretion of both the Th1 cytokine IFNg and
the Th2 cytokine IL-13. PBMC from pre-menopausal
women also secrete more IFNg and IL-13 than PBMC
from post-menopausal women.
Because this sex difference is apparent in the younger
subjects aged less than 50 years, but not in those aged
52 years or more, it is more likely to be linked to hor-
monal influences rather than genetic regulation. Sex
hormones can all influence immune function, as
reviewed elsewhere [17,18], though this has not been
specifically studied in relation to RV. In a recent report,
the capacity of IL-13 secreting T-cells to accumulate in
culture was shown to be greater in healthy young
women than in men [19]. Although Loza et al employed
antigen-independent stimulation of T-cells, rather than
a specific antigen, and post-menopausal women were
not investigated [19], their findings are nonetheless con-
sistent with the notion that immune function differs
between women and men.
Table 2 Median cytokine expression in unstimulated and rhinovirus 16 exposed cultures
Unstimulated RV16 Treated
Age Cytokine (pg/ml) Total cohort: Median IQ range Total cohort: Median IQ range
Total Cohort IP-10 180 77 - 499 5393 3481 - 6891 **
IFNg 0 0 - 17 1890 343 - 3915 **
IL-13 0 0 - 44 47 0 - 87 **
Female: Male: Female: Male:
Median and IQ range Median and IQ range Median and IQ range Median and IQ range
≤50 years old IP-10 150 (42 - 504) 258 (66 - 720) 4003 (2781 - 7252) 4571 (2927 - 5861)
IFNg 0 (0) 0 (0) 3423 (1766 - 4449) 969 (419 - 3525) *
IL-13 43 (20 - 67) 23 (0 - 60) 70 (51 - 306) 36 (0 - 45) *
≥52 years old IP-10 107 (75 - 370) 237 (119 - 526) 5917 (3932 - 6904) 5631 (3732 - 7153)
IFNg 0 (0) 0 (0) 1641 (205 - 4766) 1403 (158 - 3879)
IL-13 0 (0 - 46) 0 (0) 11 (0 - 177) 33 (0 - 82)
PBMC were exposed to RV16 and culture supernatant was collected at 24 hours to measure IP-10, and at 5 days to measure IFNg and IL-13. Median cytokine
values, with interquartile (IQ) range for unstimulated and RV16 exposed are shown. Data was assessed for normality and natural log transformed before group
comparisons were made using paired two-tailed t-test. Only comparisons attaining p < 0.05 were considered significant and only these p values are shown.
* Male vs. Female, RV16 treated: p < 0.01 ** Total cohort, unstimulated vs. RV16 treated: p < 0.001.
Female Male Female Male
0
5
10
d50 years t52 years
p<0.02
p<0.02
ln
 IF
N
J
Female Male Female Male
0.0
2.5
5.0
d50 years t52 years
p<0.005
p<0.05
ln
 IL
-1
3
A B
Figure 2 Adaptive immune responses to rhinovirus. PBMC from men and women were exposed to RV16 for 5 days. Culture supernatant was
collected and assayed for IFNg (A) and IL-13 (B) by ELISA. Data were natural log transformed and are shown as delta values (mean ± SEM) after
subtracting control (unstimulated) values. Data are from 14 women and 10 men ≤50 years old, and from 18 women and 20 men ≥52 years old.
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In contrast to adaptive immunity, our studies demon-
strate that many aspects of the innate immune response
to RV16 are similar in women and men. Expression of
two IFN stimulated genes and two T-cell polarizing
genes did not vary with sex, nor did concentrations of
IFNa and IP-10 in culture supernatants of RV16 stimu-
lated PBMC. A previous report has demonstrated that
women have a higher capacity for IFNa synthesis than
men [20], though in that study PBMC were stimulated
with synthetic TLR7 ligands rather than with live virus.
We must acknowledge the limitations of the current
study. Firstly, the evidence that the variations in RV16
induced IFNg and IL-13 secretion is due to specific hor-
mones is circumstantial at this stage. Oestrogen and/or
progesterone are likely candidates, especially as IFNg
and IL-13 were inversely proportional to age in women,
but not in men (Table 3). Hence, it will be important
for future studies to examine this issue in more detail
using appropriate hormone receptor agonists and
antagonists. Secondly, information on the timing of
blood collection in relation to the menstrual cycle in
our female subjects was not recorded. While this could
have influenced our findings to some degree, it is unli-
kely that the timing of blood collection explains the dif-
ferences between the male and female responses shown
in Figure 2 and Table 3. Future studies of cellular
responses to RV that involve women in the child bear-
ing years should consider this issue. Thirdly, it is possi-
ble that variations in the numbers of leukocytes between
men and women might explain some of the variations
in cytokine synthesis seen in this study. However, the
consensus in the literature is that differences in differen-
tial leukocyte counts are not sufficient on their own to
explain the variations in immune responses between
men and women, and that sex hormones have a more
profound effect on immunity [18].
It seems very likely that the RV16 induced cytokine
synthesis observed at day 5 reflects a response by anti-
gen experienced memory T-cells, especially as these
responses were abolished by depletion of CD45R0+ cells
from PBMC. We do not, however, know the extent to
which the subjects in this study had previously been
exposed to RV16 or to closely related RV strains.
Although all subjects showed a strong IFNg response to
RV16, this does not necessarily mean that all responses
were directed to RV16-specific T-cell epitopes. We may
speculate that some memory T-cells were responding to
epitopes shared across a number of RV strains. Cur-
rently, there is little information concerning T-cell epi-
topes to RV strains and this is a subject that clearly
warrants further study.
It is important to reflect on whether the ‘stronger’
adaptive immune response in pre-menopausal women is
truly associated with protection against RV. Greater
capacity for IFNg secretion would be predicted to
reduce viral shedding [13,14], though it is possible this
might be counteracted by higher IL-13 secretion. While
Corne and colleagues showed no sex difference in the
incidence of naturally acquired RV infection in a pro-
spective study [28], there is little literature available on
whether the severity of infection or duration of viral
shedding in RV infection varies with sex and age. It is
also possible that increased cytokine secretion by RV-
specific T-cells in asthmatic women might actually con-
tribute to the immunopathology of airway inflammation.
These are clearly questions that require further
investigation.
In conclusion, because adaptive immunity to RV varies
in relation to sex and age, it is imperative that these
variables are considered in the design of future studies
of RV infection and cellular immune function in respira-
tory diseases. Adult asthma is more common in women
than in men, so failure to properly match asthmatic and
control groups for sex and age may produce spurious
outcomes. Our findings are relevant to improved under-
standing of host defence against RV and will need to be
considered in the development of new treatments and
vaccines for RV infection.
Conclusions
PBMC from healthy pre-menopausal women make
stronger adaptive immune responses to RV16 than men
of the same age and PBMC from post-menopausal
women.
Additional material
Additional file 1: Innate immune responses to rhinovirus in ≥52
year olds. PBMC from older men and women (≥52 year old) were
exposed to RV16 for 24 hours. Culture supernatants were collected and
assayed for IP-10 by ELISA. Data were natural log transformed and are
presented as mean ± SEM.
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